Top Markets
Coin of the day
Pfizer Inc. Pfizer Inc.

Pfizer Inc.

PFE
Rank in Stocks #115
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells... Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Share Price
$26.60
Market Cap
$151.25B
Change (1 day)
-0.97%
Change (1 year)
220.57%
Country
US
Trade Pfizer Inc. (PFE)

Category

Price of PFE with the market cap of B
Pfizer Inc. Pfizer Inc.
PFE
$26.60
Market Capitalization of Pfizer Inc.(PFE)
Market Cap: $151.25B
As of March 2026 Pfizer Inc. has a market cap of $151.25B. This makes Pfizer Inc. the world's 115th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Pfizer Inc. from 2021 to 2026
PFE compared with Top 5 Most Popular stocks
Price of PFE Asset B Mkt. of B Results
Pfizer Inc. Pfizer Inc.
$261.66 $147.22B
$4.381T +2,875.90%
Pfizer Inc. Pfizer Inc.
$219.57 $147.22B
$3.676T +2,397.19%
Pfizer Inc. Pfizer Inc.
$217.81 $147.22B
$3.647T +2,377.17%
Pfizer Inc. Pfizer Inc.
$175.43 $147.22B
$2.937T +1,895.18%
Pfizer Inc. Pfizer Inc.
$133.15 $147.22B
$2.229T +1,414.33%